Freeline Therapeutics Holdings plc FRLN
$ 6.48
0.0%
Annual report 2022
added 12-21-2024
Freeline Therapeutics Holdings plc Balance Sheet 2011-2024 | FRLN
Annual Balance Sheet Freeline Therapeutics Holdings plc
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | - | - | - | - | - | - | - | |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
31 M | 20.7 M | 18.8 M | 12.4 M | - | - | - | - | - | - | - | - |
Total Liabilities |
34.2 M | 20.7 M | 18.8 M | 12.4 M | 9.16 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-445 M | -356 M | -216 M | -120 M | -65.8 M | - | - | - | - | - | - | - |
Total Assets |
86.6 M | 141 M | 269 M | 97.4 M | 32.1 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 118 M | 230 M | 73.7 M | - | - | - | - | - | - | - | - |
Book Value |
52.4 M | 120 M | 250 M | 85 M | 23 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
52.4 M | 120 M | 250 M | 85 M | 23 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Freeline Therapeutics Holdings plc
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 52.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 77.6 M | 20.7 M | 18 M | 15.4 M | 15.8 M | 18.8 M | - | 21.5 M | - | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -383 M | -356 M | -322 M | -291 M | -251 M | -216 M | - | -153 M | - | -120 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | 196 M | 141 M | 171 M | 201 M | 235 M | 269 M | - | 140 M | - | 97.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 113 M | 118 M | 136 M | 165 M | 196 M | 230 M | 251 M | 107 M | 52.5 M | 73.7 M | - | 55.5 M | - | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | 119 M | 120 M | 153 M | 186 M | 219 M | 250 M | - | 119 M | - | 85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 119 M | 120 M | 153 M | 186 M | 219 M | 250 M | - | 119 M | - | 85 M | - | 71.7 M | - | 23 M | - | - | - | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency